| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/04/1999 | CN1224620A Room temperature storable immunoglobulin preparation for intravenous injection |
| 08/03/1999 | US5932728 Antihistamines; antiallergens |
| 08/03/1999 | US5932717 Methods of obtaining DNA-RNA hybrids from sturgeon milt |
| 08/03/1999 | US5932694 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof |
| 08/03/1999 | US5932623 Process for the production of fruit polyphenols from unripe rosaceae fruit |
| 08/03/1999 | US5932610 Tumor necrosis factor α (TNF-α) inhibiting pharmaceuticals |
| 08/03/1999 | US5932598 Prodrugs of benzenesulfonamide-containing COX-2 inhibitors |
| 08/03/1999 | US5932576 3(5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors |
| 08/03/1999 | US5932569 Antiallergens |
| 08/03/1999 | US5932565 Vitamin D analogues |
| 08/03/1999 | US5932560 Treatment of conditions and disease |
| 08/03/1999 | US5932555 Terpenoid compound 0406TP-1 |
| 08/03/1999 | US5932470 Ectoparasite saliva proteins and apparatus to collect such proteins |
| 08/03/1999 | US5932427 In vitro assay system for identifying compositions useful for stimulating B cells |
| 08/03/1999 | US5932425 Compositions and methods for modulating cellular NF-κB activation |
| 08/03/1999 | US5932422 Determining whether transformed mammalian cell will respond to drug by measuring level of enzyme and comparing to level in normal cell, increased level of enzyme indicates resistance; diagnosing resistant tumor cells |
| 08/03/1999 | US5932247 Microcrystalline cellulose, lactose and pregelatinized starch; gelatin; croscarmellose sodium |
| 08/03/1999 | US5932243 Galenical formulations |
| 08/03/1999 | US5932218 Multideterminant peptides eliciting helper T-lymphocyte, cytotoxic T-lymphocyte, and neutralizing antibody responses against HIV-1 |
| 08/03/1999 | US5932217 Peptides which inhibit adhesion between leukocytes and endothelial cells |
| 08/03/1999 | US5932208 Compositions and methods for the use of such compositions in human therapeutics, characterized by the association of a muramyl peptide with a cytokine |
| 08/03/1999 | CA1340692C Method of potentiating an immune response and compositions therefor |
| 07/30/1999 | CA2246001A1 Novel compounds |
| 07/29/1999 | WO1999037818A1 Novel molecules of the tnf receptor superfamily and uses therefor |
| 07/29/1999 | WO1999037790A1 Human calcineurin b-like protein |
| 07/29/1999 | WO1999037781A1 Mutants of il-16, processes for their production, and their use |
| 07/29/1999 | WO1999037682A2 Antibodies against human il-12 |
| 07/29/1999 | WO1999037674A1 Secreted proteins and polynucleotides encoding them |
| 07/29/1999 | WO1999037666A1 α-KETOAMIDE INHIBITORS OF 20S PROTEASOME |
| 07/29/1999 | WO1999037651A1 Chemokine receptor antagonists and methods of use therefor |
| 07/29/1999 | WO1999037622A1 Nitrogenous heterocyclic derivatives and medicine thereof |
| 07/29/1999 | WO1999037619A1 Chemokine receptor antagonists and methods of use therefor |
| 07/29/1999 | WO1999037618A1 Phenylalanine derivatives useful as pharmaceutical agents |
| 07/29/1999 | WO1999037617A1 Chemokine receptor antagonists and methods of use therefor |
| 07/29/1999 | WO1999037329A1 Pharmaceutical formulation comprising an antibody and a citrate buffer |
| 07/29/1999 | WO1999037319A1 Method for treating inflammatory diseases using heat shock proteins |
| 07/29/1999 | WO1999037314A1 Sea cucumber carotenoid lipid fraction products and methods of use |
| 07/29/1999 | WO1999020755A3 Novel cytokine receptors |
| 07/29/1999 | WO1999012968A3 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response |
| 07/29/1999 | WO1998059063A3 Bovine adenovirus type 3 genome |
| 07/29/1999 | WO1995030750A8 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
| 07/29/1999 | CA2320624A1 Mutants of il-16, processes for their production, and their use |
| 07/29/1999 | CA2319077A1 Chemokine receptor antagonists and methods of use therefor |
| 07/29/1999 | CA2318935A1 Phagocytosis genes and uses thereof |
| 07/29/1999 | CA2318743A1 Novel molecules of the tnf receptor superfamily and uses therefor |
| 07/29/1999 | CA2318303A1 Secreted proteins and polynucleotides encoding them |
| 07/29/1999 | CA2318263A1 Method for treating inflammatory diseases using heat shock proteins |
| 07/29/1999 | CA2318100A1 Chemokine receptor antagonists and methods of use therefor |
| 07/29/1999 | CA2318088A1 Chemokine receptor antagonists and methods of use therefor |
| 07/29/1999 | CA2317920A1 Human calcineurin b-like protein |
| 07/28/1999 | EP0931544A2 NF-kB activity inhibitor |
| 07/28/1999 | EP0931145A1 Ptx sensitive g proteins, the production and use thereof |
| 07/28/1999 | EP0931138A1 Method of producing a thymic microenvironment that supports the development of dendritic cells |
| 07/28/1999 | EP0931096A2 HT m4?, METHODS OF TREATMENT AND ASSAYS, AGONISTS AND ANTAGONISTS |
| 07/28/1999 | EP0931093A1 Helicobacter pylori live vaccine |
| 07/28/1999 | EP0931084A1 1,3-dicarboxylic germanium complex and its therapeutic use |
| 07/28/1999 | EP0931075A1 Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf) |
| 07/28/1999 | EP0931063A1 N-substituted indol-3-glyoxylamid with antiasthmatic, antiallergic and immunosuppressive/immunomodulating effect |
| 07/28/1999 | EP0930896A1 Method for tolerizing a mammalian patient to administration of gene therapy virus vectors |
| 07/28/1999 | EP0930895A1 Preparation of protein/polysaccharide conjugate vaccines using homobifunctional and heterobifunctional vinylsulfones |
| 07/28/1999 | EP0930893A1 Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
| 07/28/1999 | EP0930887A2 Cancer immunotherapy using tumor cells combined with mixed lymphocytes |
| 07/28/1999 | EP0874639A4 Peptide inhibitors of a phosphotyrosine-binding domain containing protein |
| 07/28/1999 | EP0678122B1 Recombinant anti-vla4 antibody molecules |
| 07/28/1999 | CN1224429A Androstene derivs. |
| 07/27/1999 | US5929223 Nucleotide sequence of drosophila cyclic 3',5'-adenosine monophosphate responsive transcriptional activator and antagonist |
| 07/27/1999 | US5929220 Hepadnavirus receptor |
| 07/27/1999 | US5929212 CD3 specific recombinant antibody |
| 07/27/1999 | US5929074 Vsodilator, antiallergic and antiplatelet agents |
| 07/27/1999 | US5929067 N-acylating amine derivative of caprolactam compound with a carboxylic acid or derivatives to form amide derivative of caprolactam compound |
| 07/27/1999 | US5929063 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 07/27/1999 | US5929056 Accesible from readily available starting materials to be used for wound healing and in cosmetics |
| 07/27/1999 | US5929048 Treatment of conditions and disease |
| 07/27/1999 | US5928938 Isolated peptides which complex with HLA-Cw*16 molecules, and uses thereof |
| 07/27/1999 | US5928913 Herpes virus amplicon coding for antigen or immunomodulatory protein with replication-deficient helper herpes virus; for gene therapy and vaccines |
| 07/27/1999 | US5928904 Nucleic acids which code for immunoglobulin heavy chain complementarity determining region; for antibodies against interleukin 4 for treatment or diagnosis of allergies |
| 07/27/1999 | US5928893 Monoclonal antibody specific for human 4-1BB and cell line producing same |
| 07/27/1999 | US5928874 Nek1-related protein kinase |
| 07/27/1999 | US5928649 Administering interleukin or inducer concurrently with vaccine to swine or cattle |
| 07/27/1999 | US5928647 Immunization with non-replicating protein antigens. the compositions of the invention comprise a particulate-protein complex |
| 07/27/1999 | US5928644 Amino acid-immunogen complexes used to generate an immune response against a pathogen |
| 07/27/1999 | US5928643 Gene expression; medical diagnosis |
| 07/27/1999 | CA2181175C Dihydro pyrazolopyrroles |
| 07/22/1999 | WO1999036562A1 Nucleotide expression systems with reduced immunogenicity for use in gene therapy |
| 07/22/1999 | WO1999036553A2 Regulation of biological events using multimeric chimeric proteins |
| 07/22/1999 | WO1999036541A1 INTERLEUKIN-1 RECEPTOR ANTAGONIST BETA (IL-1RAβ) |
| 07/22/1999 | WO1999036508A1 Histidine kinase |
| 07/22/1999 | WO1999036507A1 Vaccine compositions and methods of modulating immune responses |
| 07/22/1999 | WO1999036439A1 Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation |
| 07/22/1999 | WO1999036438A1 HUMAN CMRF-35-H9 RECEPTOR WHICH BINDS IgM |
| 07/22/1999 | WO1999036437A1 Antibody/receptor targeting moiety for enhanced delivery of armed ligand |
| 07/22/1999 | WO1999036434A1 Liposomes comprising peptide antigens derived from x protein of hepatitis b virus |
| 07/22/1999 | WO1999036420A1 Thiophene nitrone compounds |
| 07/22/1999 | WO1999036415A1 Thioether furan nitrone compounds |
| 07/22/1999 | WO1999036406A1 Antivirals |
| 07/22/1999 | WO1999036105A2 USE OF RADIOLABELED MONOCLONAL IgM IN THERAPY FOR CANCER AND AUTOIMMUNE DISEASE |
| 07/22/1999 | WO1999036093A1 Methods of using human receptor protein 4-1bb |
| 07/22/1999 | WO1999036091A2 Method for inhibiting cd95-independent apoptosis in aids |
| 07/22/1999 | WO1999036090A1 Oral delivery of nucleic acid vaccines by particulate complexes |
| 07/22/1999 | WO1999036089A1 Genetic immunization with co-delivery of nucleic acid and cytokines in a single vehicle |